Skip to content
- NOA-12-Trial (randomized, open-label, multicenter phase 1/2 study of BIBF1120 plus reirradiation in the treatment of first or second glioblastoma recurrence)
- STUDY STATUS: active
- NOA-11-Trial (controlled clinical study to evaluate the safety and efficacy of stereotactic photodynamic therapy with 5-aminolevulinic acid in recurrent glioblastoma)
- STUDY STATUS: active
- NOA-10/GLIAA-Trial (amino-acid-PET- versus MRI-guided reirradiation in patients with recurrent glioblastoma)
- STUDY STATUS: active
- NOA-09/CeTeG-Trial (randomized phase 3 study of combined CCNU/temozolomide therapy versus standard temozolomide therapy in first-line therapy of patients with newly diagnosed MGMT-methylated glioblastoma)
- STUDY STATUS: completed
- NOA-08-Trial (Temozolomide - one week on/one week off - versus radiotherapy in first-line therapy of anaplastic astrocytomas and glioblastomas in older patients)
- STUDY STATUS: completed
- NOA-07-Trial (multicenter pilot study on the treatment of adult medulloblastoma)
- STUDY STATUS: completed
- NOA-06-Trial (prospective randomized phase 3 trial for solitary/singular brain metastases: Surgery versus surgery plus whole brain irradiation)
- STUDY STATUS: completed
- NOA-05-Trial (single-arm phase 2 study of PC chemotherapy in patients with gliomatosis cerebri)
- STUDY STATUS: completed
- NOA-04-Trial (prospective, randomized phase-3-trial in anaplastic glioma)
- STUDY STATUS: completed
- NOA-01-Trial (randomized study on radio-chemotherapy for malignant gliomas)
- STUDY STATUS: completed
